Printer Friendly

Articles from MondayMorning (April 13, 2009)

1-25 out of 25 article(s)
Title Author Type Words
A couple cups of coffee before a tough workout may lower the chances of sore muscles later on, a small study suggests. Brief article 306
A prostate cancer drug that takes a new approach to blocking tumor growth helped more than 40% of men with advanced prostate cancer, researchers reported. Brief article 229
Amylin founder won't vote for chairman's re-election. 344
An experimental cancer drug made by Japan's Takeda Pharmaceutical Co showed signs of slowing tumors growth in mice and has advanced to early human trials, company researchers said. Brief article 291
AstraZeneca Plc. Brief article 179
Bioexcel Spa. Brief article 195
Cardiome Pharma Corp. Brief article 120
Columbia University (New York) said faculty must report any conflicts of interest when publishing research, a move made six months after two US senators asked about ties between medical-device makers and the school's scientists. Brief article 217
Cytori Therapeutics Inc's (San Diego CA) CEO believes his company's Celution system that processes patient tissue into cells for a wide variety of potential medical uses could gain US approval next year and garner at least $1 billion in revenue by 2014. Brief article 323
Eli Lilly & Co. Brief article 230
Ex Bristol-Myers exec pleads guilty in Plavix case. Brief article 311
Genentech pulls psoriasis drug after brain infections. Brief article 192
Gilead Sciences Inc (Foster City CA) said its experimental drug to treat patients whose high blood pressure is not controlled by other medicines met both the primary goals of a late-stage study, sending its shares 5% higher. Brief article 319
H. Lundbeck A/S. Brief article 172
J&J cuts 900 drug jobs amid rising competition. Brief article 223
Johns Hopkins University's (Baltimore MD) medical school has adopted guidelines restricting interactions between doctors and makers of drugs and medical devices. Brief article 162
Obama establishes formal office for healthcare reform. Brief article 229
Pfizer reorganizes for Wyeth deal with Biotech focus. 382
Psilos Group, a New York venture-capital firm focused on healthcare technology and services, plans to raise a $450 million fund, its largest ever, an investor in Psilos's most recent fund said. The firm told some investors of its plans to gauge their interest in a new fund, said Tom Reilly, managing member at Fernwood Investment Management LLC in Quincy, Massachusetts. Statistical table 345
Sanofi to buy Medley in Viehbacher's second purchase. Brief article 300
Stocks surged Thursday to their highest levels in two months after banking giant Wells Fargo & Co. surprised the market with an early profit report that blew past analysts' expectations thanks to a strong pickup in its lending business. Statistical data 450
Takeda Pharmaceutical Co. Brief article 175
The Obama administration will use economic stimulus money to improve child care and disease prevention. Brief article 192
Tracking Washington: insurers that offer Medicare coverage will see a smaller increase in U.S. government payments in 2010 than in recent years, health officials said last week. 308
Weekly stock performance. Statistical table 457

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |